120 related articles for article (PubMed ID: 18623923)
1. Reactivity of human lymphocytes against autochthonous and allogeneic normal and tumor cells in vitro.
Chu EH; Stjernswärd J; Clifford P; Klein G
J Natl Cancer Inst; 1967 Oct; 39(4):595-617. PubMed ID: 18623923
[TBL] [Abstract][Full Text] [Related]
2. In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.
Khare AG; Advani SH; Gangal SG
Br J Cancer; 1981 Jan; 43(1):13-8. PubMed ID: 6450603
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of serum from rous-sarcoma-bearing chickens with autochthonous and with allogeneic tumor cells: preferential autochthonous recognition.
Wainberg MA; Markson Y; Doljanski F; Weiss DW
Int J Cancer; 1975 Jun; 15(6):985-94. PubMed ID: 168159
[TBL] [Abstract][Full Text] [Related]
4. Neuraminidase alteration of human lymphocyte reactivity to mitogens, antigens and allogenic lymphocytes.
Pauly JL; Germain MJ; Han T
J Med; 1978; 9(3):223-36. PubMed ID: 283169
[TBL] [Abstract][Full Text] [Related]
5. The relationship of lytic effects against autologous and allogeneic PHA blasts induced in human mixed lymphocyte cultures.
Porzsolt F; Heimpel H
Immunol Lett; 1984; 8(1):33-8. PubMed ID: 6235182
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte reactivity to mitogens in American visceral leishmaniasis.
Carvalho EM; Bacellar OA
Braz J Med Biol Res; 1983 Apr; 16(1):35-41. PubMed ID: 6640172
[TBL] [Abstract][Full Text] [Related]
7. Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.
Vánky F; Gorsky T; Gorsky Y; Masucci MG; Klein E
J Exp Med; 1982 Jan; 155(1):83-95. PubMed ID: 6459402
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte blastogenic responses to allogeneic leukocytes and autochthonous tumor cells in colorectal carcinoma.
Jubert AV; Talbott TM; Mazier WP; MacKeigan JM; Campos MM; Muldoon JP; Benjamin HE; Ferguson JA; Bowman HE
J Surg Oncol; 1977; 9(2):171-8. PubMed ID: 140957
[TBL] [Abstract][Full Text] [Related]
9. Proliferation of human lymphocytes by mitogen stimulated cells.
Jaroszewski J; Kurpisz M; Brelińska-Peczalska R; Lastowska M
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):283-8. PubMed ID: 749780
[TBL] [Abstract][Full Text] [Related]
10. Mycoplasma bovis suppression of bovine lymphocyte response to phytohemagglutinin.
Thomas CB; Mettler J; Sharp P; Jensen-Kostenbader J; Schultz RD
Vet Immunol Immunopathol; 1990 Oct; 26(2):143-55. PubMed ID: 2260280
[TBL] [Abstract][Full Text] [Related]
11. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
[TBL] [Abstract][Full Text] [Related]
12. Immunologic study on nasopharyngeal carcinoma patients: correlation of in vivo and in vitro reactivity to phytohemagglutinin.
Hsu MM; Lo P
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Feb; 16(1):20-32. PubMed ID: 6851721
[TBL] [Abstract][Full Text] [Related]
13. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.
Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH
Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498
[TBL] [Abstract][Full Text] [Related]
14. T-cell subsets in human lymphocytes maintained in IL-2 medium after PHA or mixed lymphocyte reaction activation.
Kurnick JT; Warrens AR; Moscicki RA; Leary CP
Clin Immunol Immunopathol; 1983 Jun; 27(3):444-51. PubMed ID: 6223760
[TBL] [Abstract][Full Text] [Related]
15. Optimization of culture conditions for activation and large-scale expansion of human T lymphocytes for bispecific antibody-directed cellular immunotherapy.
Lamers CH; van de Griend RJ; Braakman E; Ronteltap CP; Bénard J; Stoter G; Gratama JW; Bolhuis RL
Int J Cancer; 1992 Jul; 51(6):973-9. PubMed ID: 1386349
[TBL] [Abstract][Full Text] [Related]
16. Nonspecific lymphocyte cytotoxicity in patients with malignant melanoma, renal cell carcinoma, and sarcomas, and in nontumor patients.
Bukowski RM; Barna B; Deodhar SD; Hewlett JS
Cancer; 1976 Nov; 38(5):1962-7. PubMed ID: 991109
[TBL] [Abstract][Full Text] [Related]
17. Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes.
Vánky F; Klein E
Int J Cancer; 1982 May; 29(5):547-53. PubMed ID: 6178704
[TBL] [Abstract][Full Text] [Related]
18. Serologic analysis of human tumor antigens. II. Reactivity of sera from eleven osetogenic sarcoma patients against autologous and allogeneic tumor cells.
Rosenberg SA; Tondreau SC; Shoffner PC; Hyatt C; Brown JM; Thorpe W; Sindelar W
Surgery; 1979 Aug; 86(2):258-65. PubMed ID: 288177
[TBL] [Abstract][Full Text] [Related]
19. Suppression of mitogen-induced lymphocyte transformation in cigarette smokers.
Petersen BH; Steimel LF; Callaghan JT
Clin Immunol Immunopathol; 1983 Apr; 27(1):135-40. PubMed ID: 6872351
[TBL] [Abstract][Full Text] [Related]
20. Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to PHA and antigens following immunization.
de Gast GC; The TH; Schraffordt Koops H; Huiges HA; Oldhoff J; Nieweg HO
Cancer; 1975 Oct; 36(4):1289-97. PubMed ID: 1175127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
